Although DMARDs are not typically associated with neonatal disorders, they can have significant implications when used by pregnant women or breastfeeding mothers. Certain autoimmune conditions, like lupus or rheumatoid arthritis, require ongoing treatment with DMARDs even during pregnancy. The use of these drugs during this sensitive period can potentially impact the fetus and the newborn.